JNJ WD — Johnson & Johnson Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapNeutral

Annual income statement for Johnson & Johnson, fiscal year end - January 1st, USD millions except per share, conversion factor applied.

	2018 December 30th	2019 December 29th	2021 January 3rd	2022 January 2nd	2023 January 1st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	81,581	82,059	82,584	93,775	94,943
Cost of Revenue
Gross Profit	54,595	54,603	54,257	63,920	63,954
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	63,582	64,731	66,087	70,999	73,218
Operating Profit	17,999	17,328	16,497	22,776	21,725
Net Income Before Taxes	17,999	17,328	16,497	22,776	21,725
Provision for Income Taxes
Net Income After Taxes	15,297	15,119	14,414	20,878	17,941
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	15,297	15,119	14,714	20,878	17,941
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	15,297	15,119	14,714	20,878	17,941
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6.92	7.87	6.99	9.22	8.68
Dividends per Share